CLUSTER filed Sep 15, 2026 at 14:15 ET
Four Pharvaris insiders, including the CEO and President, sold a total of $2.15M in open-market shares over a 7-day window. The CEO's sale of $90K is small, but the President's $610K sale and the Chief Early Development Officer's $1.15M sale are material. The cluster is entirely sells with no buys, and the dollar value represents ~0.08% of the $2.7B market cap, falling just below the 0.1% threshold for materiality. However, the presence of derivative exercises (non-cash) preceding some sales suggests tax-related planning, but the open-market sales by senior executives are a cautionary signal for a biotech trading near its 52-week high with a 90% bullish analyst consensus.